Biotech

All Articles

Viridian eye health condition phase 3 smash hits, advancing press to competing Amgen

.Viridian Therapeutics' period 3 thyroid eye ailment (TED) clinical trial has actually struck its ow...

Bain reveals $3B fund forever scientific research companies

.With a sturdy track record for recognizing diamonds in the rough, Bain Funding Everyday Life Scienc...

Genentech's cancer restructure created 'for scientific explanations'

.The current choice to merge Genentech's 2 cancer cells teams was actually produced "medical reasons...

Tern oral GLP-1 shows 5% effective weight loss at 1 month at greatest dosage

.Terns Pharmaceuticals' selection to lose its liver ailment ambitions may yet pay off, after the bio...

Merck, Daiichi loyal early results in small mobile lung cancer with improved ADC records

.Merck &amp Co.'s long-running initiative to land a strike on little tissue lung cancer cells (SCLC)...

Boehringer, Bayer innovation bronchi cancer medications toward Astra fight

.Some people with non-small cell lung cancer cells (NSCLC) possess mutations in a genetics called hu...

MBX goes for $136M IPO to take rival to Ascendis into period 3

.MBX has expanded plans to absorb over $136 thousand from its own IPO as the biotech seeks to bring ...

Relay breast cancer cells information tee up clash with AstraZeneca's Truqap

.Relay Therapeutics has hammered its own survival goal in a first-in-human bust cancer research stud...

AZ details AI-enabled TROP2 biomarker approach for Daiichi ADC

.AstraZeneca has used artificial intelligence to create a special biomarker for its own Daiichi Sank...

AstraZeneca IL-33 drug fails to enhance COPD breathing in ph. 2

.AstraZeneca executives say they are actually "not troubled" that the breakdown of tozorakimab in a ...